Finding a better path to drug selectivity
- 30 November 2011
- journal article
- review article
- Published by Elsevier BV in Drug Discovery Today
- Vol. 16 (21-22), 985-990
- https://doi.org/10.1016/j.drudis.2011.07.010
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Molecular Mechanism of Selectivity among G Protein-Coupled Receptor Kinase 2 InhibitorsPublished by American Society for Pharmacology & Experimental Therapeutics (ASPET) ,2011
- Some Binding-Related Drug Properties are Dependent on Thermodynamic SignatureChemical Biology & Drug Design, 2010
- How Much Binding Affinity Can be Gained by Filling a Cavity?Chemical Biology & Drug Design, 2010
- Adding calorimetric data to decision making in lead discovery: a hot tipNature Reviews Drug Discovery, 2009
- Compensating Enthalpic and Entropic Changes Hinder Binding Affinity OptimizationChemical Biology & Drug Design, 2007
- Thermodynamics of Binding of a Low-Molecular-Weight CD4 Mimetic to HIV-1 gp120Biochemistry, 2006
- Adaptive inhibitors of the HIV-1 proteaseProgress in Biophysics and Molecular Biology, 2005
- Thermodynamic dissection of the binding energetics of KNI‐272, a potent HIV‐1 protease inhibitorProtein Science, 2000
- Three-Dimensional Quantitative Structure−Activity Relationship Analyses Using Comparative Molecular Field Analysis and Comparative Molecular Similarity Indices Analysis To Elucidate Selectivity Differences of Inhibitors Binding to Trypsin, Thrombin, and Factor XaJournal of Medicinal Chemistry, 1999
- Dibasic Benzo[b]thiophene Derivatives as a Novel Class of Active Site-Directed Thrombin Inhibitors. 1. Determination of the Serine Protease Selectivity, Structure−Activity Relationships, and Binding OrientationJournal of Medicinal Chemistry, 1997